Osaic Holdings
ANIP icon

Osaic Holdings’s ANI Pharmaceuticals ANIP Stock Holding History

Osaic Holdings’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$549K Buy
6,635
+4,497
+210% +$361K ﹤0.01% 3588
2026
Q1 		$164K Buy
2,138
+70
+3% +$5.46K ﹤0.01% 4301
2025
Q4 		$163K Sell
2,068
-62
-3% -$5.37K ﹤0.01% 4306
2025
Q3 		$199K Buy
2,130
+2,101
+7,245% +$171K ﹤0.01% 4216
2025
Q2 		$1.89K Sell
29
-21
-42% -$1.37K ﹤0.01% 6950
2025
Q1 		$3.35K Sell
50
-182
-78% -$10.9K ﹤0.01% 6385
2024
Q4 		$12.8K Buy
232
+204
+729% +$11.7K ﹤0.01% 5625
2024
Q3 		$1.67K Buy
28
+1
+4% +$61 ﹤0.01% 6679
2024
Q2 		$1.72K Sell
27
-1,043
-97% -$67.7K ﹤0.01% 6652
2024
Q1 		$74K Sell
1,070
-150
-12% -$9.05K ﹤0.01% 4462
2023
Q4 		$67.3K Sell
1,220
-251
-17% -$13.8K ﹤0.01% 4698
2023
Q3 		$85.4K Sell
1,471
-108
-7% -$6.23K ﹤0.01% 4620
2023
Q2 		$84.9K Buy
1,579
+1,087
+221% +$48.2K ﹤0.01% 4559
2023
Q1 		$19.5K Sell
492
-108
-18% -$4.55K ﹤0.01% 5586
2022
Q4 		$24K Buy
600
+162
+37% +$6.08K ﹤0.01% 5437
2022
Q3 		$14K Sell
438
-139
-24% -$4.76K ﹤0.01% 5817
2022
Q2 		$17K Buy
577
+564
+4,338% +$16.3K ﹤0.01% 5711
2022
Q1 		$0 Sell
13
-7
-35% -$261 ﹤0.01% 7213
2021
Q4 		$1K Hold
20
– – ﹤0.01% 7126
2021
Q3 		$1K Hold
20
– – ﹤0.01% 6965
2021
Q2 		$1K Hold
20
– – ﹤0.01% 6812
2021
Q1 		$1K Sell
20
-200
-91% -$6.26K ﹤0.01% 6606
2020
Q4 		$6K Sell
220
-113
-34% -$3.24K ﹤0.01% 5694
2020
Q3 		$9K Buy
333
+6
+2% +$179 ﹤0.01% 5305
2020
Q2 		$11K Sell
327
-704
-68% -$25.2K ﹤0.01% 5119
2020
Q1 		$42K Buy
+1,031
New +$54.8K ﹤0.01% 4089

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's ANIP Position: Q2 2026 in Review

Osaic Holdings increased its ANI Pharmaceuticals (ANIP) stake by 210% in Q2 2026, buying an estimated $361K and bringing the position to 6,635 shares worth $549K. The position accounts for ﹤0.01% of the portfolio, ranked #3588.

Osaic Holdings first reported a position in ANIP in Q1 2020 and has held it in 26 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Osaic Holdings held 6,635 shares of ANI Pharmaceuticals worth $549K as of Q2 2026.
  • Osaic Holdings bought 4,497 ANI Pharmaceuticals shares in Q2 2026, an estimated $361K.
  • ANI Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3588 holding.
  • Osaic Holdings first reported a position in ANI Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.